Hematology NewsTop US Oncology Regulator Seeks Changes in Drug StudiesFebruary 2, 2024Mixed TopicsCMLTransplant
Hematology NewsIn Transplant-Ineligible Myeloma, This Frontline Tx Is BetterDecember 15, 2023Multiple MyelomaTransplant
Oncology PracticeGVHD raises vitiligo risk in transplant recipientsDecember 15, 2023Mixed TopicsTransplant
Hematology NewsNo Benefit to Salvage Transplant in R/R Multiple MyelomaDecember 14, 2023Multiple MyelomaTransplant
Hematology NewsMRD status predicts transplant benefit in NPM1-mutated AMLDecember 13, 2023AMLTransplant
Hematology NewsSickle Cell: Good Outcomes for Haploidentical TransplantsDecember 12, 2023Bleeding DisordersAnemiaTransplant
Hematology NewsRelapsed DLBCL: With Complete Interim Response, SCT Outperforms CAR TDecember 11, 2023DLBCLTransplantB Cell LymphomaMixed TopicsCellular Therapy
Hematology NewsHematology is in the Brodsky family’s bloodDecember 6, 2023Mixed TopicsCMLBleeding DisordersTransplantThrombosisAnemiaMyelodysplastic Syndrome
Hematology NewsASH 2023: Equity, Sickle Cell, and Real-Life OutcomesDecember 4, 2023Mixed TopicsBleeding DisordersAMLThrombosisTransplantMultiple MyelomaMyelodysplastic Syndrome
Oncology PracticeMore than one-third of adults in the US could have NAFLD by 2050December 4, 2023GastroenterologyTransplantGastrointestinal Cancer
Hematology NewsDLBCL treatment options: CAR T outperforms ASCTNovember 3, 2023DLBCLCellular TherapyTransplantNon-Hodgkin Lymphoma
Hematology NewsFrontline myeloma treatments: ASCT vs. CAR TOctober 25, 2023Multiple MyelomaTransplantCellular Therapy
